International Society of Amyloidosis (ISA), a non-profit organization of Scientists and Physicians engaged in research, teaching, or practice in connection with amyloid and amyloidosis. The aims of our Society are to promote research, education, clinical studies (including diagnosis and treatment), conferences and symposia on all aspects of amyloidosis worldwide.
The Australian Amyloidosis Network's Health Professionals Workshop will be a livestream webcast event on Saturday the 22nd May. Australian amyloidosis physicians will be joined by Professor Claudio Rapezzi and Professor Morie Gertz, who will provide pre-recorded updates as well as attend real time question and answer sessions. Time not convenient? Recorded content will be available to registrants after the event. Details and registration
Johnson & Johnson Innovation together with Janssen Global Services is now inviting innovators to submit ideas aimed at optimizing AL amyloidosis disease detection and early diagnosis in the Improving DEtection of AL Amyloidosis (IDEA) QuickFire Challenge. Multiple awardees with the best products, technologies, or methodologies will receive grant funding and other support. View details
Congratulations to Dr. Joan Bladé and colleagues for hosting the XVII ISA Symposium and for transforming the Symposium into such a successful online event. Those who registered for the event may access recorded presentations, discussions, abstracts and posters at the ISA 2020 site. You’ll need to sign in with the username provided by the conference secretariat before the Symposium. If you have problems accessing this content, please email the secretariat.
The current Board of Directors of the ISA was officially elected for the next term via electronic vote on March 4, 2020.
Since 2002, the ISA has had exceptional leadership from around the world. We value their dedication and efforts that have led the organization in progressing the advancement of amyloidosis research.
Amyloid fibrils are structures in which misfolded proteins are deposited in tissue and organs. Different proteins can be deposited as amyloid in various sites of the human body. When in a piece of tissue (a so-called biopsy) these deposits are viewed under a microscope in normal light, the material looks amorphous. However, if the same deposits are viewed under an electron microscope with higher magnification, massive amounts of small non-branching amyloid fibrils can be seen. When a biopsy is stained with Congo red dye, the deposits will stain red. A characteristic feature of amyloid is that these red deposits will turn into apple green if viewed in polarized light. When amyloid deposition leads to signs and symptoms of disease it is called amyloidosis.